Furthermore, we demonstrate that NSD3 is a potential prognosis marker for pancreatic cancer, and this finding is consistent with recent studies showing that elevated NSD3 levels are correlated with poor clinical outcome, recurrence, and metastasis in breast cancer.45, 46. This evidence concerns the gene NSD3 and pancreatic neoplasm.